GSK3996401
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK3996401, covering 2025-10-03 to 2025-10-03. Get the full timeline:
Most recent: Clinical Trial Update: A First Time in Human Study to Evaluate the Safety and Tolerability of GSK3996401 Following Dosing With GSK4347859 in Healthy Participants [Phase 1]